Smart Inhalers Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Smart Inhalers Market By Product Type (Inhalers, Metered dose inhalers, Dry powder inhalers, Nebulizers), By Application (COPD and Asthma), By Distribution channel (Hospitals, Retail pharmacies and Online pharmacies) and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global Smart Inhalers Market was measured at US$ 37.4 million and is expected to hit US$ 1.5667 million by 2027 rising at a CAGR of 59.4% from 2021 to 2027. Smart Inhalers Market type of advanced inhaler that is digitally connected to apps on a phone or tablet, allowing clinicians to better manage a patient’s medical condition. Smart inhalers use Bluetooth technology to track inhaler usage, remind patients to take their prescription, and collect data to aid in care planning. Aside from respiratory disease treatment, the gadget also sends a smartphone notice when a patient reaches a high pollen or extremely polluted location, allowing the patient to select whether or not to enter the area. Smart inhalers include sensors that allow patients to automatically track how often they use their inhaler, eliminating the possibility of human error. Many countries’ public health systems have been overburdened as a result of the COVID-19 crisis, highlighting the critical need for long-term investment in health systems. As the COVID-19 epidemic spreads, the healthcare industry’s growth is projected to slow. The life sciences industry is booming thanks to rising demand for in vitro diagnostic products and increased research and development efforts around the world. However, sales in the medical technology and imaging industry are declining as a result of fewer procedures being performed and equipment procurement being delayed or postponed. In addition, after the pandemic, virtual consultations with healthcare specialists are likely to become the standard way of care delivery. Digital health will continue to grow in the coming years as telehealth transforms care delivery. Nowadays there are extensively available connected devices for asthma and COPD, particularly smart inhalers, which monitor and track drug use accurately. Smart inhalers are robust and accurate and respiratory inhalers currently available are inadequate for proper asthma and COPD care. Instead of simply offering incrementally better drugs, this scenario suggests that smart inhalers have new ways to deliver and enable patient self-management. For example, a swiss based company Sensirion has developed SDP3X which can be incorporated into smart inhalers. In 2019, collaboration between Novartis and Qualcomm, acquisition of Inspiro Medical by Opko Health, and acquisition of Gecko Health by Teva Pharmaceuticals for manufacturing smart inhalers. In September 2017, Adherium has received approval from FDA for its new Symbicort inhaler monitoring device SmartTouch for the Symbicort aerosol inhaler from AstraZeneca. In February 2017, Propeller Health collaborated with Novartis to develop a custom add-on sensor for the Breezhaler inhaler. In 2019, world’s first smart inhaler was approved by FDA-Teva’s ProAir Digihaler.


Smart Inhaler Market

MARKET SUMMARY
-
59.4%
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 59.4%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Smart Inhaler Market

  • The report on global smart inhalers market gives historical, current and future market size (US$ Mn) on the basis of product type, application, distribution channel, and geography.
  • This study analyses the global smart inhalers market dynamics in a detailed manner to identify current trends and drivers, growth opportunities and potential challenges to the key stakeholders in the operating market.
  • In addition, PBI has studied the global market to better equip customers with potential investment opportunities across region and market unmet needs.
Market Key Players
  • Adherium
  • AstraZeneca
  • Cohero health
  • GlaxoSmithKline
  • Gecko Health Innovations
  • Inspiro medical
  • Propeller Health
Growth

Smart Inhaler Market

The Global smart inhalers market is driven by growing prevalence of people suffering from asthma and copd and technological developments in the development of better smart inhalers devices and systems. Chronic respiratory diseases account for about 8.3% of the global chronic disease burden, contributing to more than 4 million deaths a year, according to figures from the WHO. COPD is believed to occur in over 210 million people worldwide, with about 300 million asthma patients expected. In addition, untapped consumer potential is expected to provide lucrative opportunities for market development in smart inhalers in emerging regions with more population and shortage of healthcare amenities, however higher costs associated with the production of smart inhalers for asthma and COPD are expected to hinder the growth of smart inhalers market due to its unaffordability in the developing countries.


North-America Got Significant Share

Smart Inhaler Market

Global smart inhalers market report provides a detailed overview of smart inhalers worldwide with specific focus on key regions such as North America, Europe, Asia pacific, Latin America, and MEA. The size of North American smart inhalers market worth estimated to US$ 23.5 million in 2020 and projected to be growing at a CAGR of 67.5% to reach US$ 311.2 million by 2025 due to improved healthcare system and facility, raising the number of patients suffering from asthma and COPD and increase in geriatric population. In 2019, Europe accounted for 35.1% and is predicted to be the second largest in the forecast period. The Asia Pacific Market is estimated to see pegged around CAGR 12.5% over the analysis timeline.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015 to 2020) and forecast (2021 to 2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Key

Key Findings of the Report

Smart Inhaler Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content


Report

Company Profile

  • Adherium
  • AstraZeneca
  • Cohero health
  • GlaxoSmithKline
  • Gecko Health Innovations
  • Inspiro medical
  • Propeller Health

Description

Global Smart Inhalers Market was measured at US$ 37.4 million and is expected to hit US$ 1.5667 million by 2027 rising at a CAGR of 59.4% from 2021 to 2027. Smart Inhalers Market type of advanced inhaler that is digitally connected to apps on a phone or tablet, allowing clinicians to better manage a patient’s medical condition. Smart inhalers use Bluetooth technology to track inhaler usage, remind patients to take their prescription, and collect data to aid in care planning. Aside from respiratory disease treatment, the gadget also sends a smartphone notice when a patient reaches a high pollen or extremely polluted location, allowing the patient to select whether or not to enter the area. Smart inhalers include sensors that allow patients to automatically track how often they use their inhaler, eliminating the possibility of human error. Many countries’ public health systems have been overburdened as a result of the COVID-19 crisis, highlighting the critical need for long-term investment in health systems. As the COVID-19 epidemic spreads, the healthcare industry’s growth is projected to slow. The life sciences industry is booming thanks to rising demand for in vitro diagnostic products and increased research and development efforts around the world. However, sales in the medical technology and imaging industry are declining as a result of fewer procedures being performed and equipment procurement being delayed or postponed. In addition, after the pandemic, virtual consultations with healthcare specialists are likely to become the standard way of care delivery. Digital health will continue to grow in the coming years as telehealth transforms care delivery. Nowadays there are extensively available connected devices for asthma and COPD, particularly smart inhalers, which monitor and track drug use accurately. Smart inhalers are robust and accurate and respiratory inhalers currently available are inadequate for proper asthma and COPD care. Instead of simply offering incrementally better drugs, this scenario suggests that smart inhalers have new ways to deliver and enable patient self-management. For example, a swiss based company Sensirion has developed SDP3X which can be incorporated into smart inhalers. In 2019, collaboration between Novartis and Qualcomm, acquisition of Inspiro Medical by Opko Health, and acquisition of Gecko Health by Teva Pharmaceuticals for manufacturing smart inhalers. In September 2017, Adherium has received approval from FDA for its new Symbicort inhaler monitoring device SmartTouch for the Symbicort aerosol inhaler from AstraZeneca. In February 2017, Propeller Health collaborated with Novartis to develop a custom add-on sensor for the Breezhaler inhaler. In 2019, world’s first smart inhaler was approved by FDA-Teva’s ProAir Digihaler.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX